Pepscan COVID-19 Update – Facility Operational
We would like to inform you that the Pepscan facility is operational. This allows us to proceed serving and supporting scientists in their work on amongst others diagnostic and vaccine related COVID-19 projects and treatment of cancer patients with personalized peptide vaccines.
By implementing a shift-schedule and additional precautionary measures to minimize physical interaction amongst our staff, we are able to continue the production and delivery of R&D and clinical peptides so far.
Our sales team works offsite, but strives like usual to provide you with quotes within 24 hours.
Please visit our product pages for further information about how Pepscan is able to support you in your peptide research, development and manufacturing activities and do not hesitate to send an information request.